According to The Insight Partners' research, the North America ECG Monitoring Equipment Market was valued at US$ 2,447.2 Million in 2024 and is expected to reach US$ 3,462.5 Million by 2031, registering a CAGR of 5.2% from 2025 to 2031.
Continuous technological advancement and increasing demand for continuous health monitoring have paved the way for smart ECG wearable devices. The increasing trend toward smart ECG wearable devices is driven mainly by the growing acceptance of smartwatches and fitness trackers integrated with ECG sensors for live heart health monitoring. For instance, Apple Watch Series 4 and later versions have an FDA-approved ECG app which helps in the detection of atrial fibrillation (AFib) and other heart conditions. Similarly, ECG functionality in the Fitbit Sense smartwatch allows users to detect irregular heart rhythms. The integration of ECG technology into wearable devices allows for continuous heart health monitoring, contrary to traditional ECG testing. The surging inclination toward long-term monitoring would allow for the early detection of heart abnormalities, possibly reducing hospital visits and healthcare expenditure. As per the JAMA Cardiology report, the detection of heart conditions via wearable ECG monitors was found to be beneficial in improving the outcome of patients and reducing mortality. Furthermore, the advancement in artificial intelligence (AI), along with key technological progress, is expected to create demand for smart ECG wearable devices. Algorithms based on artificial intelligence will analyze ECG data in real-time to provide predictive insights into problems with the heart long before it can become a significant issue. The increasing accuracy, decreasing costs, and integration of wearable ECG with telehealth platforms will lead to the era of personalized cardiovascular care, contributing to the ECG monitoring equipment market growth in the coming years.
North America ECG Monitoring Equipment Market Segmentation Analysis:
- By Product, the North America ECG Monitoring Equipment Market is segmented into Resting ECG Monitors, Stress ECG Monitors, Holter Monitors, and Cardiopulmonary Stress Testing Monitors. The Resting ECG Monitors segment is projected to expand at 4.9% CAGR during 2025 - 2031.
- By Lead Type, the North America ECG Monitoring Equipment Market is segmented into 12-Lead ECG, 3-6 Lead ECG, and Single Lead. The 12-Lead ECG segment is projected to expand at 5.4% CAGR during 2025 - 2031.
- By Technology, the North America ECG Monitoring Equipment Market is segmented into Portable (Wired) ECG System and Wireless ECG Systems. The Wireless ECG Systems segment is projected to expand at 5.6% CAGR during 2025 - 2031.
- By End User, the North America ECG Monitoring Equipment Market is segmented into Hospitals and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others. The Hospitals and Clinics segment is projected to expand at 5.6% CAGR during 2025 - 2031.
By country, the North America ECG Monitoring Equipment Market is categorized into the United States, Canada, and Mexico. The United States is projected to expand at 5.4% CAGR during 2025 - 2031.
Key players operating in the ECG Monitoring Equipment Market are Hill Rom Holding Inc, Koninklijke Philips NV, GE HealthCare Technologies Inc, Nihon Kohden Corp, CompuMed Inc., AliveCor, Inc, EB Neuro S.P.A, BPL Medical Technologies Pvt Ltd, FUKUDA DENSHI, Viatom Technology Co., Ltd., Spacelabs Healthcare, Shenzhen Mindray Bio-Medical Electronics Co Ltd, Schiller AG, custo med GmbH, Norav Medical, among others.
In January 2021, Hillrom reached a definitive agreement to acquire Bardy Diagnostics, Inc. (BardyDx), a leader in digital health and a prominent provider of ambulatory cardiac monitoring technologies. According to the terms of the agreement, Hillrom has purchased BardyDx for US$375 million in cash, along with potential future payments contingent on the achievement of specific commercial milestones. This acquisition enhances Hillrom's existing cardiology portfolio, which includes cardiac stress exercise, Holter, and resting electrocardiography (ECG) devices.
Contact Us
Phone: +1-646-491-9876
Email Id: [email protected]